Hyperacidity/GERD/Ulcers

Advertising Changes After Drug Switch to Over-the-Counter

Advertising Changes After Drug Switch to Over-the-Counter

When a drug switches from prescription-only to over-the-counter (OTC) there is a shift in the direct-to-consumer advertising (DTCA), with less presentation of potential harms and frequent omission of identification by generic names.

OMECLAMOX-PAK (omeprazole/clarithromycin/amoxicillin) 20mg/500mg/400mg capsules, tablets by Pernix

Omeclamox-Pak Now Available

Pernix Therapeutics announced that Omeclamox-Pak is now available for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.

Aceto Launches Generic Soma and Sodium Bicarbonate

Aceto Corporation announced that its generic subsidiary, Rising Pharmaceuticals, has launched Carisoprodol and Aspirin Tablets, the generic version of Meda Pharmaceutical’s Soma Compound with Aspirin Tablets, as well as Sodium Bicarbonate Tablets.

ACG: Electrical Stimulation of Esophageal Sphincter Aids GERD

Many Patients Keep Using PPIs After Negative GERD Test

Nearly half of patients continue to use proton pump inhibitors (PPIs) even after pH studies confirm that they do not have gastroesophageal reflux disease (GERD), and most do not recall being instructed to stop taking PPIs.

SRS Endoscopic System by Medigus

SRS Endoscopic System Approved for GERD

Medigus announced that the FDA has granted 501(k) clearance of its SRS endoscopic system for minimally-invasive endoluminal treatment of gastroesophageal reflux disease (GERD).

Dr. Reddy’s Launches OTC Lansoprazole

Dr. Reddy’s Laboratories announced the launch of over-the-counter (OTC) Lansoprazole delayed-release capsules, the generic version of Novartis’s Prevacid 24hr capsules.

OMECLAMOX-PAK (omeprazole/clarithromycin/amoxicillin) 20mg/500mg/400mg capsules, tablets by Pernix

Omeclamox-Pak Available for Treating H. pylori

Pernix Therapeutics Holdings has introduced Omeclamox-Pak, a ten-day therapy of omeprazole delayed-release capsules (20mg), clarithromycin tablets (500mg) and amoxicillin capsules (500mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.